Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results From VALOR-HCM

Milind Y. Desai; Kathy Wolski; Anjali Owens; Jeffrey B. Geske; Sara Saberi; Andrew Wang; Mark Sherrid; Paul C. Cremer; Neal K. Lakdawala; Albree Tower-Rader

doi:10.1161/circulationaha.124.072445

Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results From VALOR-HCM

Identifier:nobleid.org/w1/20260526/7FD62955

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/7FD62955.svg?ark=w1%2F20260526%2F7FD62955)](https://nobleid.org/work/w1/20260526/7FD62955)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results From VALOR-HCM

Identifier:nobleid.org/w1/20260526/7FD62955

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/7FD62955.svg?ark=w1%2F20260526%2F7FD62955)](https://nobleid.org/work/w1/20260526/7FD62955)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work